Hollencrest Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$13.4K 1247
2025
Q3
$13.4K Hold
100
﹤0.01% 759
2025
Q2
$12.4K Hold
100
﹤0.01% 735
2025
Q1
$12.7K Hold
100
﹤0.01% 732
2024
Q4
$14.4K Hold
100
﹤0.01% 740
2024
Q3
$14.9K Hold
100
﹤0.01% 710
2024
Q2
$12.6K Hold
100
﹤0.01% 725
2024
Q1
$18.4K Hold
100
﹤0.01% 647
2023
Q4
$18K Hold
100
﹤0.01% 653
2023
Q3
$15.9K Hold
100
﹤0.01% 659
2023
Q2
$14.1K Hold
100
﹤0.01% 713
2023
Q1
$16.8K Hold
100
﹤0.01% 672
2022
Q4
$16.9K Buy
+100
New +$18.1K ﹤0.01% 641

Other funds holding RGEN

Hollencrest Capital Management's RGEN Position: Q4 2025 in Review

Hollencrest Capital Management sold out of Repligen (RGEN) in Q4 2025, closing a stake of 100 shares — an estimated $13.4K sold.

Hollencrest Capital Management first reported a position in RGEN in Q4 2022 and held it in 12 quarters. The position peaked at $18.4K in Q1 2024. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Hollencrest Capital Management reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Hollencrest Capital Management sold 100 Repligen shares in Q4 2025, an estimated $13.4K.
  • Hollencrest Capital Management first reported a position in Repligen in Q4 2022 and held it in 12 quarters.
  • Hollencrest Capital Management's Repligen position peaked at $18.4K in Q1 2024.
  • 474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.